HEPTALAC Drug Patent Profile
When do Heptalac patents expire, and when can generic versions of Heptalac launch?
Heptalac is a drug marketed by Teva Pharms and is included in one NDA.
The generic ingredient in HEPTALAC is lactulose. There is one drug master file entry for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the lactulose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Heptalac
A generic version of HEPTALAC was approved as lactulose by PHARM ASSOC on July 30th, 1996.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HEPTALAC?
- What are the global sales for HEPTALAC?
- What is Average Wholesale Price for HEPTALAC?
Summary for HEPTALAC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 51 |
| Patent Applications: | 4,419 |
| DailyMed Link: | HEPTALAC at DailyMed |
US Patents and Regulatory Information for HEPTALAC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms | HEPTALAC | lactulose | SOLUTION;ORAL, RECTAL | 073504-001 | May 28, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |

